Pharmacokinetic interaction study evaluating the effect of BMS-275291 on the pharmacokinetics of paclitaxel and carboplatin in patients with advanced or metastatic non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Malik, SM
Hwang, JJ
Belani, CP
Galbraith, S
Bai, S
Rizvi, NA
机构：
[1] Lombardi Canc Ctr, Washington, DC USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7309
引用
收藏
页码：693S / 693S
页数：1
相关论文
共 50 条
  • [41] A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer
    Akiyama, Y
    Ohe, Y
    Tamura, T
    Sawada, M
    Inoue, A
    Kusaba, H
    Yamamoto, N
    Sekine, I
    Kunitoh, H
    Kodama, T
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (10) : 482 - 487
  • [42] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Kenzo Soejima
    Katsuhiko Naoki
    Kota Ishioka
    Morio Nakamura
    Michie Nakatani
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Hiroyuki Yasuda
    Ryosuke Satomi
    Sohei Nakayama
    Satoshi Yoda
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Keiko Ohgino
    Daisuke Arai
    Tetsuo Tani
    Aoi Kuroda
    Makoto Nishino
    Tomoko Betsuyaku
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 513 - 519
  • [43] Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancer
    Yanagitani, Noriko
    Tsuchiya, Satoshi
    Kaira, Kyoichi
    Sunaga, Noriaki
    Tsuchiya, Yukiko
    Sato, Koji
    Watanabe, Satoru
    Nomura, Shiro
    Sakai, Shuzo
    Saito, Ryusei
    Mori, Masatomo
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (05): : 487 - 491
  • [44] Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer (NSCLC).
    Miller, AA
    Case, D
    Atkins, J
    Giguere, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 649S - 649S
  • [45] Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naive patients with advanced non-small cell lung cancer
    Okamoto, Isamu
    Yamamoto, Nobuyuki
    Kubota, Kaoru
    Ohe, Yuichiro
    Nogami, Naoyuki
    Murakami, Haruyasu
    Yamaya, Hidetoshi
    Ono, Katsuhiro
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1132 - 1137
  • [46] PhaseI/II study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small lung cancer (NSCLC).
    Ono, Y
    Hino, M
    Narato, R
    Tanaka, Y
    Kamizuru, R
    Kitamura, K
    Uehara, T
    Kudoh, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 680S - 680S
  • [47] Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18
    Leighl, NB
    Paz-Ares, L
    Douillard, JY
    Peschel, C
    Arnold, A
    Depierre, A
    Santoro, A
    Betticher, DC
    Gatzemeier, U
    Jassem, J
    Crawford, J
    Tu, DS
    Bezjak, A
    Humphrey, JS
    Voi, M
    Galbraith, S
    Hann, K
    Seymour, L
    Shepherd, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2831 - 2839
  • [48] Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol®) and carboplatin in non-small cell lung cancer patients
    Terwogt, JMM
    van Tellingen, O
    Panday, VRN
    Huizing, MT
    Schellens, JHM
    Huinink, WWT
    Boschma, MUS
    Giaccone, G
    Veenhof, CHN
    Beijnen, JH
    ANTI-CANCER DRUGS, 2000, 11 (09) : 687 - 694
  • [49] Phase II study of oxaliplatin and paclitaxel in advanced non-small cell lung cancer (NSCLC).
    Mauer, AM
    Otterson, G
    Rudin, CM
    Villalona, M
    Ansari, RH
    Szeto, L
    Vokes, EE
    CLINICAL CANCER RESEARCH, 2000, 6 : 4576S - 4576S
  • [50] Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Lazaro, M
    Jorge, M
    Castellanos, J
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
12345